Corcept Therapeutics (CORT)
|
2.07
-0.01 (-0.48%)
|
|
|
|
CORT additional information
Market Data powered by QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Filings and Fundamentals by Morningstar, Insiders by Vickers (USA) and SEDI(CDN), analyst ratings by Zacks.
CORT Profile
•
Exchange
NASDAQ
•
Held by these Mutual Funds
Vanguard Extended Market Idx
DFA US Micro Cap I
iShares Russell 2000 Growth Index
DFA US Small Cap I
iShares Russell Microcap Index
Live Oak Health Sciences
AST Federated Aggressive Growth
Saratoga Health & Biotechnology A
Vanguard Instl Ttl Stk Mkt Idx InstlPlus
Vanguard Balanced Index
DFA US Micro Cap I
iShares Russell 2000 Growth Index
DFA US Small Cap I
iShares Russell Microcap Index
Live Oak Health Sciences
AST Federated Aggressive Growth
Saratoga Health & Biotechnology A
Vanguard Instl Ttl Stk Mkt Idx InstlPlus
Vanguard Balanced Index
•
Executives
Dr. Joseph K. Belanoff M.D.
Co-Founder
Chief Exec. Officer and Director
Dr. Robert L. Roe M.D. A.C.P
71
Pres and Sec.
Mr. Gary Charles Robb
Chief Financial Officer
Ms. Anne M. LeDoux
Chief Accounting Officer
VP and Controller
Mr. Steven Lo
VP of Commercial Operations
Co-Founder
Chief Exec. Officer and Director
Dr. Robert L. Roe M.D. A.C.P
71
Pres and Sec.
Mr. Gary Charles Robb
Chief Financial Officer
Ms. Anne M. LeDoux
Chief Accounting Officer
VP and Controller
Mr. Steven Lo
VP of Commercial Operations
•
Employee Count
17
Special Offers
Competitors
CORT earnings
Date
Actual
Expected
Prev Yr Qtr
10/31/2012
-0.08
-0.09
-0.08
5/3/2012
-0.13
-0.11
-0.09
3/5/2012
-0.12
-0.09
-0.10
